Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 2 | 2023 | 160 | 1.220 |
Why?
|
| Transplants | 1 | 2023 | 18 | 0.940 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2014 | 2 | 0.500 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 352 | 0.360 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 644 | 0.360 |
Why?
|
| Aldosterone | 2 | 2007 | 8 | 0.290 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2007 | 64 | 0.280 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2007 | 93 | 0.280 |
Why?
|
| Myocytes, Cardiac | 3 | 2007 | 137 | 0.270 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 491 | 0.220 |
Why?
|
| Social Class | 1 | 2023 | 110 | 0.220 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 642 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 271 | 0.180 |
Why?
|
| Celiac Disease | 1 | 2017 | 11 | 0.150 |
Why?
|
| Mass Screening | 1 | 2017 | 370 | 0.120 |
Why?
|
| Female | 3 | 2023 | 28441 | 0.090 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2005 | 6 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2007 | 101 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2007 | 614 | 0.070 |
Why?
|
| Fenofibrate | 1 | 2007 | 16 | 0.070 |
Why?
|
| Hypolipidemic Agents | 1 | 2007 | 33 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2007 | 64 | 0.070 |
Why?
|
| Myocardium | 2 | 2007 | 441 | 0.070 |
Why?
|
| Cycloheximide | 1 | 2005 | 32 | 0.070 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 19 | 0.070 |
Why?
|
| Dactinomycin | 1 | 2005 | 23 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 181 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 39 | 0.070 |
Why?
|
| Spironolactone | 1 | 2005 | 5 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2005 | 65 | 0.070 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2005 | 4 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2005 | 40 | 0.060 |
Why?
|
| Humans | 3 | 2023 | 54284 | 0.060 |
Why?
|
| Tyrosine | 1 | 2005 | 137 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2005 | 271 | 0.060 |
Why?
|
| Middle Aged | 2 | 2017 | 13088 | 0.050 |
Why?
|
| Hypertension | 1 | 2007 | 564 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 1663 | 0.050 |
Why?
|
| Heart Failure | 1 | 2005 | 541 | 0.040 |
Why?
|
| Rats | 1 | 2005 | 3415 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2017 | 28 | 0.040 |
Why?
|
| North America | 1 | 2017 | 68 | 0.040 |
Why?
|
| Gastroenterology | 1 | 2017 | 20 | 0.040 |
Why?
|
| Animals | 3 | 2007 | 14385 | 0.030 |
Why?
|
| Fibrosis | 2 | 2007 | 208 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 692 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1025 | 0.030 |
Why?
|
| Male | 3 | 2017 | 27334 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2007 | 614 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 3431 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2007 | 11 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2007 | 12 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2007 | 16 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 198 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 514 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 32 | 0.020 |
Why?
|
| Cell Size | 1 | 2005 | 45 | 0.020 |
Why?
|
| Ligation | 1 | 2005 | 64 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 52 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 75 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 6897 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2005 | 104 | 0.020 |
Why?
|
| Mice | 2 | 2007 | 6413 | 0.020 |
Why?
|
| Pressure | 1 | 2005 | 120 | 0.020 |
Why?
|
| Myocarditis | 1 | 2005 | 44 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 158 | 0.020 |
Why?
|
| Random Allocation | 1 | 2005 | 312 | 0.020 |
Why?
|
| Aorta | 1 | 2005 | 177 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 1737 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 10054 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 587 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 14207 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 3213 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 958 | 0.010 |
Why?
|
| Apoptosis | 1 | 2005 | 1300 | 0.010 |
Why?
|